Showing 1 - 10 of 20,703
discusses the details of the intellectual property (IP) Chapter. Significantly, it does not contain substantive TRIPS …
Persistent link: https://www.econbiz.de/10012604269
. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …
Persistent link: https://www.econbiz.de/10011509446
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to … to be compliant with this provision of TRIPS by 2005. This study investigates two questions in this context: (1) How does …
Persistent link: https://www.econbiz.de/10011992779
Persistent link: https://www.econbiz.de/10012433548
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10012433847
Persistent link: https://www.econbiz.de/10012433977
Persistent link: https://www.econbiz.de/10012434041
Persistent link: https://www.econbiz.de/10012433517
outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members … then, the issue of the relationship between patent protection and the development of and access to medical treatments and … between IP, innovation, access, and public health between stakeholders with divergent interests. This working paper provides …
Persistent link: https://www.econbiz.de/10012303912